|
NARG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26469999999868E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.92300000000567E-05 |
| Normal-vs-Stage2 |
1.474640E-01 |
| Normal-vs-Stage3 |
7.604700E-03 |
| Normal-vs-Stage4 |
7.253900E-02 |
| Stage1-vs-Stage2 |
5.181400E-01 |
| Stage1-vs-Stage3 |
8.772000E-01 |
| Stage1-vs-Stage4 |
5.989600E-01 |
| Stage2-vs-Stage3 |
5.186400E-01 |
| Stage2-vs-Stage4 |
9.776200E-01 |
| Stage3-vs-Stage4 |
5.429200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0094000000046E-05 |
| Normal-vs-AfricanAmerican |
5.741800E-03 |
| Normal-vs-Asian |
2.791200E-04 |
| Caucasian-vs-AfricanAmerican |
6.084800E-01 |
| Caucasian-vs-Asian |
3.512400E-01 |
| AfricanAmerican-vs-Asian |
2.300000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.04810000035283E-07 |
| Normal-vs-Female |
1.299000E-01 |
| Male-vs-Female |
2.894400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.260450E-03 |
| Normal-vs-Extreme_Weight |
2.47310000000001E-05 |
| Normal-vs-Obese |
1.663650E-02 |
| Normal-vs-Extreme_Obese |
7.514200E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.856400E-01 |
| Normal_Weight-vs-Obese |
3.076200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.762800E-01 |
| Extreme_Weight-vs-Obese |
1.168170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.434800E-01 |
| Obese-vs-Extreme_Obese |
5.281600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.558900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.131610E-02 |
| Normal-vs-Age(61-80Yrs) |
4.45149999994676E-06 |
| Normal-vs-Age(81-100Yrs) |
5.756100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.373000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.915400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.017800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.066300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.388200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.204190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.985410E-04 |
| Normal-VS-Type2 PRCC |
2.15739999999132E-05 |
| Normal-VS-KIRP CIMP |
1.182420E-02 |
| Normal-VS-Unclassified PRCC |
5.842100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.301590E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.942200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.425600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.599400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.083400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.312600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.32790000504113E-08 |
| Normal-vs-N1 |
7.019600E-02 |
| Normal-vs-N2 |
1.831300E-04 |
| N0-vs-N1 |
8.537000E-03 |
| N0-vs-N2 |
3.862000E-01 |
| N1-vs-N2 |
6.812200E-02 |
|
|
